Back

HFpEF management: state of the art SGLT2 inhibitors.

28 August 2021 (09:41 - 09:52)
Organised by:
Congress Presentation Part of: How-To manage HFpEF: state of the art in 2021 Chronic Heart Failure ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Rudolf De Boer

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
HFpEF management: state of the art neurohumoral modulation.
Professor S. Solomon (Boston, US)
Slides Video
Presentation thumbnail
HFpEF management: state of the art novel devices.
Professor D. Kaye (Melbourne, AU)
Slides Video
Presentation thumbnail
How-To manage HFpEF: state of the art in 2021 – discussion.
Presentation thumbnail
How-To manage HFpEF: state of the art in 2021 - Chat Moderator.

Access the full session

Session thumbnail
How-To manage HFpEF: state of the art in 2021
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

28 August 2021 09:41 CET
You may be interested in
thumbnail
Congress Presentation
SGLT2i in heart failure with reduced ejection fraction: benefits in real life?
22 May 2023
thumbnail
Congress Presentation
HFmrEF/HFpEF across the spectrum: a case-based workshop​
30 August 2025
thumbnail
Congress Presentation
Effects of sodium-glucose cotransporter-2 inhibitors on left ventricular-arterial coupling and myocardial extracellular volume in patients with type 2 diabetes mellitus and HFpEF
29 August 2025
thumbnail
Congress Session
Innovative drug therapies in heart failure
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources